	_id	name	date	mutations
28	pmid33525415	Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.	2021-01-18	K26R
29	pmid33525415	Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.	2021-01-18	P426A
53	2020.04.23.057042	ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an in silico study	2020-04-24	S19P
54	2020.04.23.057042	ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an in silico study	2020-04-24	K26R
150	pmid32558308	Genetic variability of human angiotensin-converting enzyme 2 (hACE2) among various ethnic populations.	2020-05-15	K26R
151	pmid32558308	Genetic variability of human angiotensin-converting enzyme 2 (hACE2) among various ethnic populations.	2020-05-15	I468V
204	pmid32997488	Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor.	2021-01-01	D614G
279	2021.02.24.21251989	Virological and serological characterization of critically ill patient with COVID-19 in the UK: a special focus on variant detection	2021-03-05	D1118H
309	2020.12.20.423630	Mutation Landscape of SARS COV2 in Africa	2020-12-21	L84S
310	2020.12.20.423630	Mutation Landscape of SARS COV2 in Africa	2020-12-21	L3606F
312	2020.12.20.423630	Mutation Landscape of SARS COV2 in Africa	2020-12-21	V378I
313	2020.12.20.423630	Mutation Landscape of SARS COV2 in Africa	2020-12-21	G251V
314	2020.12.20.423630	Mutation Landscape of SARS COV2 in Africa	2020-12-21	P323L
315	2020.12.20.423630	Mutation Landscape of SARS COV2 in Africa	2020-12-21	Q57H
316	2020.12.20.423630	Mutation Landscape of SARS COV2 in Africa	2020-12-21	D614G
319	2020.12.20.423630	Mutation Landscape of SARS COV2 in Africa	2020-12-21	V367F
320	2020.12.20.423630	Mutation Landscape of SARS COV2 in Africa	2020-12-21	D364Y
321	2020.12.20.423630	Mutation Landscape of SARS COV2 in Africa	2020-12-21	V483A
322	2020.12.20.423630	Mutation Landscape of SARS COV2 in Africa	2020-12-21	G476S
546	2021.03.23.21254158	The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males.	2021-03-26	L412F
607	pmid33513449	Different SARS-CoV-2 haplotypes associate with geographic origin and case fatality rates of COVID-19 patients.	2021-01-18	D614G
797	pmid32868447	A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.	2020-12-18	D614G
805	pmid33718878	Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawai'i Reveals the Worldwide Emerging P681H Mutation.	2021-03-16	P681H
808	pmid33718878	Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawai'i Reveals the Worldwide Emerging P681H Mutation.	2021-03-16	D614G
925	pmid33725111	Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.	2020-12-24	L37F
926	pmid33725111	Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.	2020-12-24	P323L
927	pmid33725111	Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.	2020-12-24	F506L
928	pmid33725111	Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.	2020-12-24	S507G
929	pmid33725111	Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.	2020-12-24	D614G
930	pmid33725111	Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.	2020-12-24	Q57H
931	pmid33725111	Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.	2020-12-24	T1198K
932	pmid33725111	Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.	2020-12-24	A97V
933	pmid33725111	Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.	2020-12-24	T315N
934	pmid33725111	Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.	2020-12-24	P13L
1098	2020.04.10.029454	Three adjacent nucleotide changes spanning two residues in SARS-CoV-2 nucleoprotein: possible homologous recombination from the transcription-regulating sequence	2020-04-11	R203K
1099	2020.04.10.029454	Three adjacent nucleotide changes spanning two residues in SARS-CoV-2 nucleoprotein: possible homologous recombination from the transcription-regulating sequence	2020-04-11	G204R
1100	2020.04.10.029454	Three adjacent nucleotide changes spanning two residues in SARS-CoV-2 nucleoprotein: possible homologous recombination from the transcription-regulating sequence	2020-04-11	D614G
1167	pmid33472904	A novel point mutation in the N gene of SARS-CoV-2 may affect the detection of the virus by RT-qPCR.	2021-01-21	C26340T
1168	pmid33472904	A novel point mutation in the N gene of SARS-CoV-2 may affect the detection of the virus by RT-qPCR.	2021-01-21	C29200T
1169	pmid33472904	A novel point mutation in the N gene of SARS-CoV-2 may affect the detection of the virus by RT-qPCR.	2021-01-21	C29200A
1222	pmid33662863	Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?	2021-03-06	C677T
1350	2021.03.31.21254660	Qualitatively distinct modes of Sputnik V vaccine-neutralization escape by SARS-CoV-2 Spike variants	2021-04-02	E484K
1441	pmid33622851	Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hot Spots, Functional Cross Talk, and Regulatory Interactions in SARS-CoV-2.	2021-02-24	T1103P
1442	pmid33622851	Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hot Spots, Functional Cross Talk, and Regulatory Interactions in SARS-CoV-2.	2021-02-24	P409L
1443	pmid33622851	Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hot Spots, Functional Cross Talk, and Regulatory Interactions in SARS-CoV-2.	2021-02-24	Y446C
1444	pmid33622851	Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hot Spots, Functional Cross Talk, and Regulatory Interactions in SARS-CoV-2.	2021-02-24	D614G
1613	2020.10.30.362954	Genetic diversity analysis of the D614G mutation in SARS-CoV-2	2020-11-02	D614G
1629	pmid33774075	A novel single nucleotide polymorphism assay for the detection of N501Y SARS-CoV-2 variants.	2021-03-17	N501Y
1649	2021.02.13.431090	A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation	2021-02-17	A1114G
1650	2021.02.13.431090	A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation	2021-02-17	T372A
1651	2021.02.13.431090	A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation	2021-02-17	D614G
1742	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	A348V
1743	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	V367F
1744	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	A419S
1745	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	T323I
1746	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	A344S
1747	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	R408I
1748	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	G476S
1749	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	V483A
1750	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	H519Q
1751	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	A520S
1752	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	A522S
1753	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	K529E
1760	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	A930V
1761	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	D936Y
1762	pmid32884216	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.	2020-09-28	D1168H
1893	pmid33837182	GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein.	2021-04-10	R203K
1894	pmid33837182	GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein.	2021-04-10	G204R
1913	pmid33109270	Molecular detection of drug resistant polymorphisms in Plasmodium falciparum isolates from Southwest, Nigeria.	2020-11-05	S679S
1914	pmid33109270	Molecular detection of drug resistant polymorphisms in Plasmodium falciparum isolates from Southwest, Nigeria.	2020-11-05	M699V
1915	pmid33109270	Molecular detection of drug resistant polymorphisms in Plasmodium falciparum isolates from Southwest, Nigeria.	2020-11-05	S769M
1916	pmid33109270	Molecular detection of drug resistant polymorphisms in Plasmodium falciparum isolates from Southwest, Nigeria.	2020-11-05	C580Y
2206	pmid33254541	Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia?	2020-07-31	C677T
2232	pmid33496683	The Novel Coronavirus Enigma: Phylogeny and Analyses of Coevolving Mutations Among the SARS-CoV-2 Viruses Circulating in India.	2020-07-25	A97V
2233	pmid33496683	The Novel Coronavirus Enigma: Phylogeny and Analyses of Coevolving Mutations Among the SARS-CoV-2 Viruses Circulating in India.	2020-07-25	L37F
2277	pmid33635624	Sequence-Specific Detection of ORF1a, BRAF, and ompW DNA Sequences with Loop Mediated Isothermal Amplification on Lateral Flow Immunoassay Strips Enabled by Molecular Beacons.	2021-02-26	V600E
2287	2021.04.12.21255337	Rapid, inexpensive methods for exploring SARS CoV-2 D614G mutation	2021-04-19	D614G
2289	2021.04.12.21255337	Rapid, inexpensive methods for exploring SARS CoV-2 D614G mutation	2021-04-19	A23403G
2299	2020.07.19.197129	Population genetic analysis of Indian SARS-CoV-2 isolates reveals a unique phylogenetic cluster	2020-07-20	C22444T
2300	2020.07.19.197129	Population genetic analysis of Indian SARS-CoV-2 isolates reveals a unique phylogenetic cluster	2020-07-20	C28854T
2301	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	S19P
2302	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	I21V
2303	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	E23K
2304	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	K26R
2305	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	T27A
2306	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	N64K
2307	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	T92I
2308	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	Q102P
2309	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	H378R
2310	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	K31R
2311	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	N33I
2312	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	H34R
2313	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	E35K
2314	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	E37K
2315	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	D38V
2316	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	Y50F
2317	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	N51S
2318	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	M62V
2319	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	K68E
2320	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	F72V
2321	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	Y83H
2322	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	G326E
2323	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	G352V
2324	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	D355N
2325	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	Q388L
2326	pmid33846513	Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.	2021-04-14	D509Y
2352	pmid33759544	Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in coronavirus disease-2019 patients.	2021-03-24	C3435T
2400	2020.06.04.135293	Characterization of the substitution hotspots in SARS-CoV-2 genome using BioAider and detection of a SR-rich region in N protein providing further evidence of its animal origin	2020-06-05	Y541C
2435	pmid33144203	Intrahost non-synonymous diversity at a neutralising antibody epitope of SARS-CoV-2 spike protein N-terminal domain.	2020-09-22	G22017T
2439	pmid33144203	Intrahost non-synonymous diversity at a neutralising antibody epitope of SARS-CoV-2 spike protein N-terminal domain.	2020-09-22	W152L
2501	pmid33468702	SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia.	2021-01-22	D614G
2564	2020.08.07.242263	Worldwide tracing of mutations and the evolutionary dynamics of SARS-CoV-2	2020-08-12	F400L
2565	2020.08.07.242263	Worldwide tracing of mutations and the evolutionary dynamics of SARS-CoV-2	2020-08-12	T164I
2566	2020.08.07.242263	Worldwide tracing of mutations and the evolutionary dynamics of SARS-CoV-2	2020-08-12	Q6383H
2604	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	S19P
2605	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	I21V
2606	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	E23K
2607	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	K26R
2608	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	T27A
2609	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	N64K
2610	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	T92I
2611	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	Q102P
2612	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	H378R
2614	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	K31R
2615	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	N33I
2616	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	H34R
2617	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	E35K
2618	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	E37K
2619	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	D38V
2620	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	Y50F
2621	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	N51S
2622	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	M62V
2623	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	K68E
2624	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	F72V
2625	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	Y83H
2626	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	G326E
2627	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	G352V
2628	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	D355N
2629	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	Q388L
2630	2020.04.07.024752	Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility	2020-04-10	D509Y
2669	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	S19P
2670	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	I21T
2671	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	E23K
2672	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	A25T
2673	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	K26R
2674	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	T27A
2675	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	E35D
2676	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	E37K
2677	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	Y50F
2678	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	N51D
2679	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	M62V
2680	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	N64K
2681	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	K68E
2682	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	F72V
2683	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	E75G
2684	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	M82I
2685	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	T92I
2686	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	Q102P
2687	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	G220S
2688	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	H239Q
2689	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	G326E
2690	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	E329G
2691	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	G352V
2692	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	D355N
2693	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	H378R
2694	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	Q388L
2695	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	P389H
2696	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	E467K
2697	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	H505R
2698	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	R514G
2699	pmid32423095	The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.	2020-05-03	Y515C
2777	2020.07.07.20148213	No evidence of viral polymorphisms associated with Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS).	2020-07-08	D614G
2924	2021.01.12.426365	The lethal triad: SARS-CoV-2 Spike, ACE2 and TMPRSS2. Mutations in host and pathogen may affect the course of pandemic.	2021-01-14	D614G
2926	2021.01.12.426365	The lethal triad: SARS-CoV-2 Spike, ACE2 and TMPRSS2. Mutations in host and pathogen may affect the course of pandemic.	2021-01-14	A570D
2927	2021.01.12.426365	The lethal triad: SARS-CoV-2 Spike, ACE2 and TMPRSS2. Mutations in host and pathogen may affect the course of pandemic.	2021-01-14	P681H
2928	2021.01.12.426365	The lethal triad: SARS-CoV-2 Spike, ACE2 and TMPRSS2. Mutations in host and pathogen may affect the course of pandemic.	2021-01-14	T716I
2929	2021.01.12.426365	The lethal triad: SARS-CoV-2 Spike, ACE2 and TMPRSS2. Mutations in host and pathogen may affect the course of pandemic.	2021-01-14	N501Y
2935	pmid33452303	SARS-CoV-2 infection susceptibility influenced by ACE2 genetic polymorphisms: insights from Tehran Cardio-Metabolic Genetic Study.	2021-01-18	K26R
2936	pmid33452303	SARS-CoV-2 infection susceptibility influenced by ACE2 genetic polymorphisms: insights from Tehran Cardio-Metabolic Genetic Study.	2021-01-18	S331F
2972	2021.01.06.425497	Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H Mutation	2021-01-07	P681H
2975	2021.01.06.425497	Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H Mutation	2021-01-07	D614G
2988	pmid32964802	Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms.	2020-10-10	W461R
2989	pmid32964802	Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms.	2020-10-10	G405E
2990	pmid32964802	Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms.	2020-10-10	F588S
2991	pmid32964802	Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms.	2020-10-10	P391S
2992	pmid32964802	Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms.	2020-10-10	C12S
2993	pmid32964802	Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms.	2020-10-10	G1223A
3100	pmid33357220	Malaria and COVID-19: unmasking their ties.	2020-12-31	C1173T
3109	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	I21T
3110	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	A25T
3111	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	K26R
3112	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	E37K
3113	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	T55A
3114	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	E75G
3115	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	I21V
3116	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	E23K
3117	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	K26E
3118	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	T27A
3119	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	E35K
3120	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	S43R
3121	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	Y50F
3122	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	N51D
3123	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	N58H
3124	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	K68E
3125	pmid33181224	Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.	2020-10-06	M82I
3238	2020.04.10.029454	Three adjacent nucleotide changes spanning two residues in SARS-CoV-2 nucleoprotein: possible homologous recombination from the transcription-regulating sequence	2020-04-11	spike D614G
3280	2021.02.13.431090	A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation	2021-02-17	Spike D614G
